Statistical consideration for clinical biomarker research in bladder cancer.
about
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancerA 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder--Possible Clinical Implications.Neural correlates of chronic low back pain measured by arterial spin labeling.Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand.Personalized therapy for urothelial cancer: review of the clinical evidence.Prognostic implications of preoperative anemia in urothelial carcinoma: A meta-analysis.Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cellsRisk of cancer-specific mortality following recurrence after radical nephroureterectomy.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.Immunohistochemical biomarkers for bladder cancer prognosis.Current status of molecular markers for prognostication and outcome in invasive bladder cancer.Biomolecular predictors of urothelial cancer behavior and treatment outcomes.DNA methylation-based biomarkers in bladder cancer.Molecular markers in bladder cancer: Novel research frontiers.Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.Building bridges in urothelial carcinoma to face common challenges.Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy.Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy.From genomics to imaging-advances along the care continuum.Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
P2860
Q26798006-41C86806-E00C-4353-B348-AE483B97CC47Q30421675-C1FEA4C7-55A9-4095-9513-3DC0CD3F5FEDQ33721258-4FD2E5B5-F880-497A-9974-27310E634328Q35176013-EB1BDAA7-16F7-4C3D-B654-81ADA17F13C1Q35644340-1519F7AE-449C-4EFC-98AC-A4903452F7C9Q35751445-E375EE09-5605-448E-A0B0-C3132D36FD04Q35778645-CE765196-FD34-4F4E-946F-8E6A723C8D34Q35982594-DFCFE690-5D6E-4702-A882-56D80217CB36Q36062762-DEDB119D-61DD-40BC-A283-F801B031DC39Q36275572-6F331E39-4401-400D-98D1-5005C2F0C915Q36347268-154D256B-A61E-4B94-B2AC-C6FBA9D87611Q36623107-DDE3E479-0D15-4CB2-870A-CE3B8A61AC19Q37714579-23BFC1BC-C6A1-494C-A267-E8E5E77A4849Q37731119-0E8A6F6B-2EBA-4881-91D4-8E9E4B5E5622Q37874869-BDA80231-0DFA-4BF6-AA6C-D4DC03F46F71Q37902697-287247DC-87D2-4BF5-B8AD-45F7EB09C55CQ37974674-0C902E1C-5991-48DA-A17B-9F4EC41BE660Q37987066-59306EB1-6482-47DC-8A0C-F7F48DB8F07CQ38102879-33C0FE11-2345-471E-81A9-5A0DD0597624Q38520403-E162ECF0-DD5D-41D2-9D8F-C2B257B020B3Q38946859-240427FA-2D18-4E6C-AFF2-A175ABF78D9CQ40763465-493F8EEA-CEC5-4776-9F50-A0D6430B993EQ42381612-8D1556A5-E8A8-4ED8-8BBA-BC34CBE1EEBAQ44293813-3E50121C-9317-433F-A284-13F5122727E4Q46569857-9F6DA30F-0DBE-4900-BC32-E64A687AF2C3Q50227392-B45BE456-CBE3-4F00-85AD-E77CA95FD865Q50577725-61563726-D737-4042-A70A-8A48771DE6D5
P2860
Statistical consideration for clinical biomarker research in bladder cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Statistical consideration for clinical biomarker research in bladder cancer.
@ast
Statistical consideration for clinical biomarker research in bladder cancer.
@en
type
label
Statistical consideration for clinical biomarker research in bladder cancer.
@ast
Statistical consideration for clinical biomarker research in bladder cancer.
@en
prefLabel
Statistical consideration for clinical biomarker research in bladder cancer.
@ast
Statistical consideration for clinical biomarker research in bladder cancer.
@en
P2093
P2860
P50
P1433
P1476
Statistical consideration for clinical biomarker research in bladder cancer.
@en
P2093
Bernd J Schmitz-Dräger
Peter J Goebell
Pierre I Karakiewicz
Shahrokh F Shariat
P2860
P304
P356
10.1016/J.UROLONC.2010.02.011
P577
2010-07-01T00:00:00Z